Together we will beat cancerDonate
A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’.
The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.
Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.
A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.
A new treatment for people with multiple myeloma will now be available on the NHS in England.
NICE will undertake a methodological study into patient health preferences after receiving a £120,000 grant courtesy of Myeloma UK.
Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment.
Find out about blood stem cell donation, how you could get involved and even help save someone’s life
Survival rates for people with blood cancer have improved across Europe, but variations still exist from country to country.